Danaher Additional Paid-in Capital 2012-2026 | DHR
Danaher additional paid-in capital from 2012 to 2026. Additional paid-in capital can be defined as the excess over par value paid for common securities.
- Danaher additional paid-in capital for the quarter ending March 31, 2026 was $17.076B, a 83.53% increase year-over-year.
- Danaher additional paid-in capital for 2024 was $16.727B, a 3.44% increase from 2023.
- Danaher additional paid-in capital for 2023 was $16.17B, a 33.95% increase from 2022.
- Danaher additional paid-in capital for 2022 was $12.072B, a 19.64% increase from 2021.
|
Danaher Annual Additional Paid-in Capital (Millions of US $) |
|
|---|---|
| 2024 | $16,727 |
| 2023 | $16,170 |
| 2022 | $12,072 |
| 2021 | $10,090 |
| 2020 | $9,698 |
| 2019 | $7,565 |
| 2018 | $5,834 |
| 2017 | $5,538 |
| 2016 | $5,313 |
| 2015 | $4,981 |
| 2014 | $4,481 |
| 2013 | $4,158 |
| 2012 | $3,688 |
| 2011 | $3,877 |
|
Danaher Quarterly Additional Paid-in Capital (Millions of US $) |
|
|---|---|
| 2025-09-30 | $17,076 |
| 2025-06-30 | $16,960 |
| 2025-03-31 | $16,845 |
| 2024-12-31 | $16,727 |
| 2024-09-30 | $9,304 |
| 2024-06-30 | $9,806 |
| 2024-03-31 | $14,215 |
| 2023-12-31 | $16,170 |
| 2023-09-30 | $14,085 |
| 2023-06-30 | $13,939 |
| 2023-03-31 | $12,130 |
| 2022-12-31 | $12,072 |
| 2022-09-30 | $11,985 |
| 2022-06-30 | $11,854 |
| 2022-03-31 | $10,123 |
| 2021-12-31 | $10,090 |
| 2021-09-30 | $10,004 |
| 2021-06-30 | $9,890 |
| 2021-03-31 | $9,794 |
| 2020-12-31 | $9,698 |
| 2020-09-30 | $9,618 |
| 2020-06-30 | $9,475 |
| 2020-03-31 | $7,630 |
| 2019-12-31 | $7,565 |
| 2019-09-30 | $7,502 |
| 2019-06-30 | $7,483 |
| 2019-03-31 | $7,376 |
| 2018-12-31 | $5,834 |
| 2018-09-30 | $5,772 |
| 2018-06-30 | $5,706 |
| 2018-03-31 | $5,611 |
| 2017-12-31 | $5,538 |
| 2017-09-30 | $5,472 |
| 2017-06-30 | $5,424 |
| 2017-03-31 | $5,371 |
| 2016-12-31 | $5,313 |
| 2016-09-30 | $5,263 |
| 2016-06-30 | $5,221 |
| 2016-03-31 | $5,073 |
| 2015-12-31 | $4,981 |
| 2015-09-30 | $4,887 |
| 2015-06-30 | $4,728 |
| 2015-03-31 | $4,624 |
| 2014-12-31 | $4,481 |
| 2014-09-30 | $4,381 |
| 2014-06-30 | $4,285 |
| 2014-03-31 | $4,220 |
| 2013-12-31 | $4,158 |
| 2013-09-30 | $4,089 |
| 2013-06-30 | $4,013 |
| 2013-03-31 | $3,887 |
| 2012-12-31 | $3,688 |
| 2012-09-30 | $3,962 |
| 2012-06-30 | $4,134 |
| 2012-03-31 | $4,016 |
| 2011-12-31 | $3,877 |
| 2011-09-30 | $3,801 |
| 2011-06-30 | $3,747 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $126.118B | $24.568B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS Health (CVS) | United States | $129.251B | 14.33 |
| Elevance Health (ELV) | United States | $85.740B | 12.83 |
| HCA Healthcare (HCA) | United States | $83.631B | 13.02 |
| Cencora (COR) | United States | $52.781B | 16.27 |
| Natera (NTRA) | United States | $32.768B | 0.00 |
| Labcorp Holdings (LH) | United States | $20.863B | 15.10 |
| Viatris (VTRS) | United States | $17.911B | 6.28 |
| DiDi Global (DIDIY) | China | $16.365B | 25.64 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.375B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $13.258B | 54.19 |
| Medpace Holdings (MEDP) | United States | $13.014B | 28.64 |
| Solventum (SOLV) | United States | $12.739B | 11.79 |
| Revvity (RVTY) | United States | $11.049B | 19.34 |
| ICON (ICLR) | Ireland | $10.775B | 12.49 |
| BioMerieux (BMXMF) | France | $9.232B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.745B | 18.16 |
| HealthEquity (HQY) | United States | $7.074B | 23.57 |
| Sonic Healthcare (SKHHY) | Australia | $6.895B | 0.00 |
| Avantor (AVTR) | United States | $6.384B | 11.00 |
| PACS (PACS) | United States | $5.978B | 24.21 |
| GETINGE (GNGBY) | Sweden | $5.438B | 17.36 |
| Bausch + Lomb (BLCO) | Canada | $5.331B | 22.97 |
| CochLear (CHEOY) | Australia | $5.195B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $4.893B | 0.00 |
| Sotera Health (SHC) | United States | $4.489B | 19.92 |
| Alignment Healthcare (ALHC) | United States | $4.401B | 236.56 |
| Concentras Parent (CON) | United States | $3.646B | 19.78 |
| Organon (OGN) | United States | $3.519B | 4.27 |
| Establishment Labs Holdings (ESTA) | United States | $2.533B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 13.19 |
| Progyny (PGNY) | United States | $2.059B | 34.13 |
| Pediatrix Medical (MD) | United States | $1.932B | 11.59 |
| Surgery Partners (SGRY) | United States | $1.903B | 58.20 |
| Agilon Health (AGL) | United States | $1.887B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.732B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $1.704B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.645B | 65.20 |
| Teladoc Health (TDOC) | United States | $1.368B | 0.00 |
| Ardent Health (ARDT) | United States | $1.294B | 5.51 |
| CareDx (CDNA) | United States | $1.294B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.250B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| Omada Health (OMDA) | United States | $1.069B | 0.00 |
| Nutex Health (NUTX) | United States | $1.033B | 11.60 |
| GoodRx Holdings (GDRX) | United States | $0.880B | 16.06 |
| CryoPort (CYRX) | United States | $0.744B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Strata Critical Medical (SRTA) | United States | $0.498B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Oncology Institute (TOI) | United States | $0.495B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.389B | 4.74 |
| Shoulder Innovations (SI) | United States | $0.369B | 0.00 |
| Forward Industries (FWDI) | United States | $0.319B | 0.00 |
| SBC Medicals (SBC) | United States | $0.303B | 7.56 |
| LifeMD (LFMD) | United States | $0.208B | 0.00 |
| Embecta (EMBC) | United States | $0.180B | 1.17 |
| Biodesix (BDSX) | United States | $0.180B | 0.00 |
| So-Young (SY) | China | $0.159B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.100B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.087B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.086B | 14.28 |
| Park Dental Partners (PARK) | United States | $0.082B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| DocGo (DCGO) | United States | $0.053B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.017B | 0.00 |
| Ainos (AIMD) | United States | $0.016B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Pomdoctor - (POM) | China | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.010B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |